An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Completed

• Conditions: Coronary Artery Disease

• Registration Number: NCT02420808
• Lead Sponsor: Hellenic Cardiovascular Research Society

Brief Summary

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Detailed Description

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Study Timeline

• Study Start: 2012-03
• Primary Completion: 2013-06
• Study Completion: 2014-01
• Study First Submitted: 2015-04-15
• Study First Submitted QC: 2015-04-17
• Study First Posted: 2015-04-20
• Status Verified: 2017-03
• Last Update Submitted: 2017-03-01
• Last Update Posted: 2017-03-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

• Informed Consent
• > 25 years
• Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms.
• Acute Coronary Syndrom

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of patients with Acute Coronary Syndromes.	6 months	Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.

Secondary Outcome Measures

Name	Time	Method
Estimation of the percentage of patients.	Baseline	Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina.
Description of the methods of patients' evacuation.	Baseline	Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS.
Description of the administered medication.	Baseline - 6 months	Description of the pharmaceutical treatment administered during hospitalization and monitoring period.
Estimation of the interval until the arrival in the hospital.	Baseline	Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations.
Evaluation of the blood test analysis during hospitalization.	Baseline	Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization.
Evaluation of the male patients with erectile dysfunction.	Baseline - 6 months	Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome.

Trial Locations

Locations (1)

General Hospital of Chalkida; 🇬🇷 Chalkida, Greece